Lenvatinib/programmed cell death-1 receptor antagonistsPain: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2022年 / 1906卷 / 1期
关键词：
D O I：
10.1007/s40278-022-15129-7
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：239 / 239
相关论文
共 50 条
  • [1] Programmed cell death-1 receptor antagonists/vemurafenibElevated transaminase: case report
    Reactions Weekly, 2020, 1825 (1) : 185 - 185
  • [2] Gemcitabine/paclitaxel/programmed cell death-1 receptor antagonistsPneumonitis: case report
    Reactions Weekly, 2021, 1857 (1) : 161 - 161
  • [3] Dabrafenib/programmed cell death-1 receptor antagonists/trametinibDevelopment of drug resistance and fever: case report
    Reactions Weekly, 2019, 1768 (1) : 122 - 122
  • [4] Lenvatinib/Programmed-cell-death-1-receptor-antagonistsHypothyroidism
    Reactions Weekly, 2024, 2008 (1) : 187 - 187
  • [5] Drug of the year: Programmed Death-1 receptor/Programmed Death-1 Ligand-1 receptor monoclonal antibodies
    Robert, Caroline
    Soria, Jean-Charles
    Eggermont, Alexander M. M.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (14) : 2968 - 2971
  • [6] Capecitabine/oxaliplatin/programmed cell death-1 receptor antagonistsGastrointestinal reaction, myelosuppression and Eggerthia catenaformis bacteraemia: case report
    Reactions Weekly, 2020, 1817 (1) : 95 - 95
  • [7] Lenvatinib Targets FGF Receptor 4 to Enhance Antitumor Immune Response of Anti-Programmed Cell Death-1 in HCC
    Yi, Chenhe
    Chen, Lirong
    Lin, Zhifei
    Liu, Lu
    Shao, Weiqing
    Zhang, Rui
    Lin, Jing
    Zhang, Jubo
    Zhu, Wenwei
    Jia, Huliang
    Qin, Lunxiu
    Lu, Lu
    Chen, Jinhong
    HEPATOLOGY, 2021, 74 (05) : 2544 - 2560
  • [8] Programmed Cell Death-1/Programmed Cell Death-1 Ligand as Prognostic Markers of Coronavirus Disease 2019 Severity
    Niedzwiedzka-Rystwej, Paulina
    Majchrzak, Adam
    Aksak-Was, Bogusz
    Serwin, Karol
    Czajkowski, Zenon
    Grywalska, Ewelina
    Korona-Glowniak, Izabela
    Rolinski, Jacek
    Parczewski, Milosz
    CELLS, 2022, 11 (12)
  • [9] Lenvatinib/unspecified programmed-cell-death-1-receptor-antagonistsLack of efficacy: 2 case reports
    Reactions Weekly, 2025, 2042 (1) : 252 - 252
  • [10] Lenvatinib/unspecified programmed-cell-death-1-receptor-antagonistsVarious toxicities : 8 case reports
    Reactions Weekly, 2024, 2021 (1) : 282 - 282
12345